DUBLIN--(BUSINESS WIRE)--The "Chronic Kidney Disease Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.
The latest report from, Chronic Kidney Disease Pipeline Highlights - 2017 Update, provides most up-to-date information on key pipeline products in the global Chronic Kidney Disease market. It covers emerging therapies for Chronic Kidney Disease in active clinical development stages including early and late stage clinical trials.
The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Chronic Kidney Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Chronic Kidney Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Chronic Kidney Disease pipeline products by the company.
Short-term Launch Highlights:
Find out which Chronic Kidney Disease pipeline products will be launched in the US and Ex-US till 2020.
Key Topics Covered:
1. Chronic Kidney Disease Pipeline by Stages
2. Chronic Kidney Disease Pipeline by Drug Class
3. Chronic Kidney Disease Pipeline by Company
4. Chronic Kidney Disease Phase 3 Clinical Trial Insights
5. Chronic Kidney Disease Phase 2 Clinical Trial Insights
6. Chronic Kidney Disease Phase 1 Clinical Trial Insights
7. Chronic Kidney Disease Preclinical Research Insights
8. Chronic Kidney Disease Discovery Stage Insights
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/xz8llk/chronic_kidney?w=4